Trials / Unknown
UnknownNCT02307994
Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH
Effectiveness and Safety of uFSH for Severe Oligospermia or Azoospermia:A Multi-center,Open,Randomized,Interventional,and Phase4 Trial in China
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Livzon Pharmaceutical Group Inc. · Industry
- Sex
- Male
- Age
- 25 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 75IU uFSH |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-06-01
- First posted
- 2014-12-04
- Last updated
- 2014-12-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02307994. Inclusion in this directory is not an endorsement.